Skip to content

Clinical trials

Phase 3 Acquired Immunodeficiency Syndrome trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Acquired Immunodeficiency Syndrome Phase: Phase 3 Country / region: Germany Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20051
20073
20081
20117
20121
20131
20152
20163
20181
20191
20211
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Active, not recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ViiV Healthcare10
Gilead Sciences4
Tibotec Pharmaceuticals, Ireland3
Janssen-Cilag International NV2
GlaxoSmithKline1
Janssen R&D Ireland1
Janssen Sciences Ireland UC1
Janssen-Cilag G.m.b.H1
NEAT ID Foundation1
National Institute of Allergy and Infectious Diseases (NIAID)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Acquired Immunodeficiency Syndrome28
HIV Infections16
Infections7
Cytomegalovirus Infections1
Hepatitis B, Chronic1
Hepatitis C, Chronic1
Occupational Injuries1
Virus Diseases1

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.